Related Experiment Video
Updated: Apr 18, 2026
10:32
Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
15.7K
Leprosy: diagnosis and management in a developed setting
D Turner1, S L McGuinness, S McGuiness
1Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Internal Medicine Journal
|January 14, 2015
Summary
Diagnosis of leprosy is often delayed in developed countries, particularly when patients exhibit leprosy reactions instead of typical skin lesions or neuropathy. Early recognition of diverse symptoms is crucial for timely treatment.
Area of Science:
- Medical Research
- Infectious Diseases
- Dermatology
Background:
- Leprosy (Hansen's disease) is a significant global health issue.
- Limited data exists on leprosy diagnosis and management in developed nations.
- Delayed diagnosis in developed settings is a suspected challenge.
Purpose of the Study:
- To investigate the patterns and reasons for delayed leprosy diagnosis in a developed country setting.
- To analyze the clinical presentations associated with delayed diagnosis.
Main Methods:
- Retrospective review of all leprosy cases.
- Data collected from a major tertiary referral center.
- Analysis of cases diagnosed between 1999 and 2013.
Main Results:
- Delay in leprosy diagnosis is common in developed settings.
- Patients presenting with leprosy reactions experienced longer diagnostic delays.
- Classical symptoms like skin lesions and neuropathy were sometimes absent or overlooked.
Conclusions:
- Diagnostic delays for leprosy are prevalent in developed healthcare systems.
- Leprosy reactions can mask or mimic other conditions, complicating diagnosis.
- Awareness of varied presentations is essential for prompt diagnosis and management.
Related Concept Videos
01:28Pulmonary Tuberculosis V
943
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
943
01:26Pulmonary Tuberculosis IV
758
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
758
01:31Pulmonary Tuberculosis III
1.6K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.6K
01:29Pulmonary Tuberculosis I
1.6K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.6K
01:28Pulmonary Tuberculosis II
2.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.4K
01:26Psychosis: Goals of Pharmacotherapy
689
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
689